SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : North American Vaccine -- Ignore unavailable to you. Want to Upgrade?


To: Rick Strange who wrote (369)6/5/1998 8:32:00 AM
From: Don W Stone  Respond to of 507
 
Rick: I am really surprised that the "midnite fax" would comment on NVX at this stage. "He" was maintaining the respect of his subscribers by not talking about NVX anymore. Many I know think he is absolutely wrong on NVX. They are more convinced now than ever that NVX should have been one of his long recommendations.
It is the same old stuff. It indicates that at this point the shorts haven't a clue as to what is going on here. That is the interpretation that an informed investor would get.
Now what i am really saying is that the shorts do have a little clue and that is why they bring up the same old arguments. They are gropping to find an uninformed NVX investor out there who owns a lot of NVX and will sell on there ridiculous arguments. NOISE, NOISE, NOISE.
Fat chance.
I guess we will never hear a short talk about NVX/CERTIVA's exceptional "safety profile", or CERTIVA-IPV, or NVX's pipeline of leading blockbuster vaccines like meningitis C vaccine and Group B Strep.
Nor will we hear about the problems that the other players are really having with their developement of truly "combination vaccines"
And as to HiB I won't rely on the shorts for the real world situation here either. Today it is only being tested as a true "combination vaccine" by NVX in Europe to my knowledge.
Nor will we hear much about existing or potential major alliances or partnerships.
Let us just say the shorts are ever so focused. Call it "tunnel vision". :-}